Hints and tips:
...Lilly uses online pharmacies Truepill and Amazon Pharmacy to dispense its medicines, in a move driven in part by huge demand for its popular weight-loss drug....
...Pfizer is “trying to leverage some of that brand equity that they got the world spinning again”, said Markus Saba, a marketing professor at the University of North Carolina Center for the Business of Health...
...“Is the biosimilar market a failure with respect to these pharmacy benefit drugs like Humira?...
...CVS Health, the largest pharmacy chain in the US, in 2018 acquired Aetna for $69bn and Cigna combined with Express Scripts in a $67bn deal, including debt....
...However, she has since struggled with weakening vaccine demand, rising retail competition and wavering consumer spending, which have also weighed on rival CVS Health....
...The FTC’s detailed opposition to the Horizon deal focuses on so-called pharmacy benefit managers. These businesses determine which drug prescriptions are eligible for health insurance reimbursement....
...The FTC had contended that Amgen could get buyers such as health insurers or pharmacy benefit managers to favour Horizon’s drugs by bundling them with its own best-selling medicines....
...Its — untested — argument is that Amgen could use rebates on its blockbusters to encourage insurers and pharmacy benefit managers to favour Horizon’s drugs....
...US health officials last week warned that some pharmacies were running out of storage space for the drug just weeks after distribution began because of tepid demand....
...However, the FTC’s case against Amgen is targeted at the power the company allegedly wields more broadly with health insurers and middlemen in the US healthcare system, known as pharmacy benefit managers...
...The FTC argued that Amgen could use the rebates it pays on its “blockbuster” drugs to press insurance companies and pharmacy benefit managers into paying for two of Horizon’s medicines: Tepezza for an autoimmune...
...It required the six largest pharmacy benefit managers, which negotiate fees and rebates with drug manufacturers, to share information on their business practices....
...Amgen said it would offer its biologic treatment, named Amjevita, to US health insurers and middlemen known as pharmacy benefit managers through two pricing plans....
...Finding and assessing prospects in the pharma market takes time, according to Denton, an experienced dealmaker who when working as chief financial officer at pharmacy giant CVS in 2018 oversaw its $68bn...
...This includes a large pharmacy benefit management business and a leading health insurance division. Walgreens remains overly dependent on its nearly 9,000 stores in the US....
...News of the deal comes months after Walgreens was forced to abandon its planned sale of the Boots pharmacy chain in the UK after struggling to draw interest from buyers, a move it blamed on market conditions...
...He said inflationary pressure in the health and beauty market was not as severe as in other sectors, running at about 3.5 per cent....
...Building a mid-life start-up was hard on his family and on his health....
...Goldman Sachs was engaged to review options for the business as Walgreens’ new chief executive, Roz Brewer, opted to focus on health and wellness in its home market....
...Walgreens Boots Alliance said this week that a review launched in January had concluded the US group should retain ownership of the UK pharmacy and beauty retailer for now....
...The US pharmaceutical company supplied the drug to Flynn, which then sold the capsules to wholesalers and pharmacies at a price between 2,300 per cent and 2,600 per cent higher than the prices previously...
.... ©2022 Nikkei Inc....
...Boots derives about 45 per cent of its revenue from providing services to the UK’s state-run health service, including prescriptions and vaccinations....
.... ©2021 Nikkei Inc....
...India’s second-richest man Mukesh Ambani and US buyout group Apollo Global Management are planning a joint bid for UK high street pharmacy chain Boots, according to people familiar with the matter....
International Edition